European Medicines Agency recommends approval of sofosbuvir for the treatment of chronic hepatitis C

View source ↗

Summary

The EMA recommended approval of sofosbuvir for treating chronic hepatitis C, indicating a potential new therapy option for patients with this infection in Europ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Sofosbuvir (sofosbuvir)